Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Plant Physiology
|
August 23, 2024
A cyclical marker system enables indefinite series of oligonucleotide-directed gene editing in Chlamydomonas reinhardtii
Ian L Ross, Hong Phuong Le, Sabar Budiman, et al.
BMC Psychiatry
|
May 23, 2013
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
David H Adams, Bruce J Kinon, Simin Baygani, et al.
Schizophrenia Research
|
September 17, 2013
Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
Virginia L Stauffer, Brian A Millen, Scott Andersen, et al.
The American Surgeon
|
August 20, 2020
An Early Case of Fat Embolism Syndrome Occurring Following Polytrauma
Janelle-Cheri A Millen, Carrie Watson, John M Cain, et al.
Journal of Animal Science
|
January 3, 2018
Gene expression analysis of blood, liver, and muscle in cattle divergently selected for high and low residual feed intake
M Khansefid, C A Millen, Y Chen, et al.
BMC Genomics
|
November 5, 2018
Comparing allele specific expression and local expression quantitative trait loci and the influence of gene expression on complex trait variation in cattle
Majid Khansefid, Jennie E Pryce, Sunduimijid Bolormaa, et al.
Journal of Clinical Psychopharmacology
|
April 22, 2011
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia
Bruce J Kinon, Lu Zhang, Brian A Millen, et al.
Journal of Personalized Medicine
|
February 11, 2016
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia
Laura K Nisenbaum, AnnCatherine M Downing, Fangyi Zhao, et al.
BMC Genomics
|
November 25, 2015
Extensive variation between tissues in allele specific expression in an outbred mammal
Amanda J Chamberlain, Christy J Vander Jagt, Benjamin J Hayes, et al.
Biochemistry
|
June 14, 2012
Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species
Bruno Macedo, Thiago A Millen, Carolina A C A Braga, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Plant Physiology
|
August 23, 2024
A cyclical marker system enables indefinite series of oligonucleotide-directed gene editing in Chlamydomonas reinhardtii
Ian L Ross, Hong Phuong Le, Sabar Budiman, et al.
BMC Psychiatry
|
May 23, 2013
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
David H Adams, Bruce J Kinon, Simin Baygani, et al.
Schizophrenia Research
|
September 17, 2013
Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
Virginia L Stauffer, Brian A Millen, Scott Andersen, et al.
The American Surgeon
|
August 20, 2020
An Early Case of Fat Embolism Syndrome Occurring Following Polytrauma
Janelle-Cheri A Millen, Carrie Watson, John M Cain, et al.
Journal of Animal Science
|
January 3, 2018
Gene expression analysis of blood, liver, and muscle in cattle divergently selected for high and low residual feed intake
M Khansefid, C A Millen, Y Chen, et al.
BMC Genomics
|
November 5, 2018
Comparing allele specific expression and local expression quantitative trait loci and the influence of gene expression on complex trait variation in cattle
Majid Khansefid, Jennie E Pryce, Sunduimijid Bolormaa, et al.
Journal of Clinical Psychopharmacology
|
April 22, 2011
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia
Bruce J Kinon, Lu Zhang, Brian A Millen, et al.
Journal of Personalized Medicine
|
February 11, 2016
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia
Laura K Nisenbaum, AnnCatherine M Downing, Fangyi Zhao, et al.
BMC Genomics
|
November 25, 2015
Extensive variation between tissues in allele specific expression in an outbred mammal
Amanda J Chamberlain, Christy J Vander Jagt, Benjamin J Hayes, et al.
Biochemistry
|
June 14, 2012
Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species
Bruno Macedo, Thiago A Millen, Carolina A C A Braga, et al.
Page
of 4